What accounts for the variation in COVID-19 vaccine hesitancy in Eastern, Southern and Western Europe?
Covid-19
Media consumption
Public opinion
Trust
Vaccination
Vaccine hesitancy
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
11 05 2023
11 05 2023
Historique:
received:
22
11
2022
revised:
03
03
2023
accepted:
15
03
2023
medline:
16
5
2023
pubmed:
15
4
2023
entrez:
14
4
2023
Statut:
ppublish
Résumé
In the wake of mass COVID-19 vaccination campaigns in 2021, significant differences in vaccine skepticism emerged across Europe, with Eastern European countries in particular facing very high levels of vaccine hesitancy and refusal. This study investigates the determinants of COVID-19 vaccine hesitancy and refusal, with a focus on these differences across Eastern, Southern and Western Europe. The statistical analyses are based on individual-level survey data comprising quota-based representative samples from 27 European countries from May 2021. The study finds that demographic variables have complex associations with vaccine hesitancy and refusal. The relationships with age and education are non-linear. Trust in different sources of health-related information has significant associations as well, with people who trust the Internet, social networks and 'people around' in particular being much more likely to express vaccine skepticism. Beliefs in the safety and effectiveness of vaccines have large predictive power. Importantly, this study shows that the associations of demographic, belief-related and other individual-level factors with vaccine hesitancy and refusal are context-specific. Yet, explanations of the differences in vaccine hesitancy across Eastern, Southern and Eastern Europe need to focus on why levels of trust and vaccine-relevant beliefs differ across regions, because the effects of these variables appear to be similar. It is the much higher prevalence of factors such as distrust of national governments and medical processionals as sources of relevant medical information in Eastern Europe that are relevant for explaining the higher levels of vaccine skepticism observed in that region.
Identifiants
pubmed: 37059674
pii: S0264-410X(23)00314-6
doi: 10.1016/j.vaccine.2023.03.030
pmc: PMC10070781
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3178-3188Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Hum Vaccin Immunother. 2022 Nov 30;18(5):2074716
pubmed: 35714274
BMC Public Health. 2018 Jan 30;18(1):196
pubmed: 29378545
Vaccines (Basel). 2021 Mar 12;9(3):
pubmed: 33808958
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccines (Basel). 2022 Aug 18;10(8):
pubmed: 36016237
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
Vaccine. 2022 Nov 28;40(50):7262-7269
pubmed: 36333226
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Vaccines (Basel). 2022 Sep 28;10(10):
pubmed: 36298496
Vaccine. 2022 Sep 9;40(38):5615-5620
pubmed: 36008231
Soc Sci Med. 2021 Dec;291:114480
pubmed: 34662759
Vaccine. 2022 Nov 28;40(50):7280-7287
pubmed: 36334965
PLoS One. 2022 Jun 1;17(6):e0267734
pubmed: 35648748
Vaccines (Basel). 2021 Aug 06;9(8):
pubmed: 34452000
J Health Soc Behav. 2021 Mar;62(1):85-99
pubmed: 33533672
Int J Environ Res Public Health. 2021 Jan 16;18(2):
pubmed: 33467179
Vaccines (Basel). 2021 Feb 17;9(2):
pubmed: 33671437
J Health Commun. 2020 Oct 2;25(10):808-815
pubmed: 33719888
Nat Hum Behav. 2021 Nov;5(11):1528-1534
pubmed: 34002053
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
Vaccine. 2022 Apr 14;40(17):2498-2505
pubmed: 34218963
Soc Sci Med. 2020 Nov;265:113414
pubmed: 33038683
BMJ Glob Health. 2020 Oct;5(10):
pubmed: 33097547
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Aug 07;9(8):
pubmed: 34452001
Int J Public Health. 2020 Apr;65(3):325-333
pubmed: 32277246
Vaccine. 2022 Feb 23;40(9):1191-1197
pubmed: 35125225
Soc Sci Q. 2021 Sep;102(5):2124-2133
pubmed: 34908608
J Med Internet Res. 2021 Nov 8;23(11):e30150
pubmed: 34570715
Soc Sci Q. 2021 Sep;102(5):2106-2123
pubmed: 34908607
Eur J Public Health. 2022 Aug 1;32(4):636-642
pubmed: 35522721
Soc Sci Med. 2014 Jul;112:1-11
pubmed: 24788111
PLoS One. 2023 Mar 1;18(3):e0282420
pubmed: 36857365
Vaccine. 2019 Mar 7;37(11):1491-1494
pubmed: 30755366
Vaccine. 2021 Jun 29;39(29):3935-3939
pubmed: 34116875
Front Psychol. 2021 Feb 03;11:609658
pubmed: 33613364
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Soc Sci Q. 2021 Sep;102(5):2341-2359
pubmed: 34226771
Vaccines (Basel). 2021 Oct 19;9(10):
pubmed: 34696314
Soc Sci Med. 2023 Mar;321:115759
pubmed: 36774703
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Nat Hum Behav. 2022 Dec;6(12):1634-1648
pubmed: 35995837
BMJ Open. 2021 Jun 15;11(6):e048172
pubmed: 34130963